Press Releases
Constella Biomedical Informatics Executive to Moderate DIA Panel
Experts to Discuss Using Web-Based Collaborative Systems for Faster, More Efficient R&D
SAN ANTONIO, TEXAS, June 12, 2003—Robert Henley, vice president of business strategy for Constella Biomedical Informatics, will moderate a panel discussion at the 39th annual Drug Information Association (DIA) meeting on using Web-based collaborative systems to improve bio/pharmaceutical research and development.
The DIA meeting will be held June 15-19 at the Henry B. Gonzalez Convention Center in San Antonio. Henley's panel will present from 2 until 3:30 p.m on Tuesday, June 17.
The presentation, titled "Faster, More Efficient R&D Through Collaborative Services Technologies," focuses on the emerging area of using collaborative service models and technologies to store, retrieve and reuse knowledge across the R&D enterprise in order to find better answers, using a variety of R&D resources more efficiently.
Panel participants include Barbara E. Tardiff, M.D., M.B.A., vice president of clinical informatics for Regeneron Pharmaceuticals, Inc.; Meredith Nahm, director of clinical data integration at Duke Clinical Research Institute, Duke University; and Peter Spiers, global head of strategy and systems architecture, development IT for Novartis Pharmaceuticals, Inc., UK.
Participants will discuss how leading biotech and pharmaceutical companies have deployed Web-based collaborative systems to provide their R&D teams with easy, but secure, access to real-time, analysis-ready data in order to get the answers they need faster. Participants will present a variety of case studies about collaborative processes, such as "net-sourcing," to speed R&D performance and improve economic efficiency.
Henley will also speak on "The Future of R&D Processes: Collaborative Biomedical Informatics."
"We live in a new age of the 'Biological Economy' in which our economic process and models are increasingly revolving around research and development across all areas of the life sciences," said Henley. "However, our capacity to process and understand biomedical R&D information is limited, from both a shortage of specialized people and from underdeveloped technological processes to make those people more efficient. To thrive, biotechnology firms, biopharmaceutical companies, contract research organizations, product commercialization groups, and health-related government and academic centers must aggregate and disseminate biomedical knowledge for scientific advancement and commercialization faster then ever."
At Constella Biomedical Informatics, Henley manages the sales process for the promotion, sale and support of the business' products and services. Henley also provides leadership in the integrated and strategic areas of product management, marketing management and sales management. He has more than 17 years of technical, engineering, operational, marketing and sales experience in the field of information technology. Henley earned a bachelor of science degree in industrial technology-manufacturing engineering with a minor in digital electronic systems from the University of Maryland.
About Constella Biomedical Informatics
Constella Biomedical Informatics (formerly mednetics LLC) is a leading regulatory informatics business whose systems provide clients with complete, secure and regulatory-compliant control of their vital knowledge-from discovery to clinical, and from manufacturing to marketing. The business is a trusted steward of regulatory informatics data, serving The New Biological Economy and enhancing human health by safeguarding the data of life™.
About Constella Group, Inc.
Constella Biomedical Informatics is a business unit of Constella Group, Inc., formerly Analytical Sciences, Inc. (ASI), is a leading provider of professional health services worldwide, now celebrating 20 years of enhancing human health through innovative science, technology and knowledge solutions. Constella's three business units—Health Sciences, Biomedical Informatics and Health Strategies—conduct health research and provide a variety of technical, professional and strategic consulting services to help industry and government clients identify and solve problems affecting human health. With Constella as the parent company, the three business units comprise dynamic points of collaboration that build support, create momentum and add value from idea to impact across the full continuum of human health.
back to top